QP Motion Sickness Tablet 8 CT Recalled for Improper Storage Conditions
Family Dollar Stores is recalling QP Motion Sickness Tablet 8 CT (SKU 901583) packages distributed nationwide from April 30 to June 10, 2022, due to improper storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard involves improper storage temperature conditions, a CGMP deviation, which is a precautionary recall without demonstrated harm.
Plain-English summary
Family Dollar Stores, Llc. is recalling QP Motion Sickness Tablet 8 CT packages for a Current Good Manufacturing Practice (CGMP) deviation. The product was held outside appropriate storage temperature conditions during distribution.
The affected product (SKU 901583) was distributed nationwide to specific Family Dollar Stores between April 30, 2022, and June 10, 2022. This is an FDA Class II recall.
No illnesses or injuries have been reported. Consumers who have purchased this product should consult their healthcare provider with any questions about the recall or their health.
The recalled product
- Product
- QP MOTION SICKNESS TABLET 8 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 901583
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27